Phase
Condition
Bunion
Treatment
Placebo
Local anesthetic injection of CPL-01
Naropin, 0.5% Injectable Solution
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Ability to sign ICF
Bunion for elective primary unilateral, distal, first metatarsal bunionectomy withosteotomy and internal fixation under regional anesthesia, without collateralprocedures or additional surgeries
BMI ≤ 39 kg/m2
If biologically female, not pregnant or planning to become pregnant over the study
If biologically male, either sterile or using acceptable form of birth control
Be willing and able to complete study procedures
Exclusion
Exclusion Criteria:
Has previously undergone unilateral simple bunionectomy.
Has a planned concurrent surgical procedure
Has a concurrent painful condition that may require analgesic treatment during thestudy period or may confound postsurgical pain assessments
Has a history or clinical manifestation of significant medical, neuropsychiatric, orother condition that could preclude or impair study participation or interfere withstudy assessments.
Has a history of malignant hyperthermia or glucose-6-phosphate dehydrogenasedeficiency.
Has history or evidence of impaired liver function (e.g., alanine aminotransferase [ALT] > 3 × upper limit of normal [ULN] or total bilirubin > 2 × ULN), activehepatic disease, or cirrhosis.
Has history or evidence of impaired renal function (e.g., creatinine > 1.5 × ULN).
Has a history of malignancy in the past year
Has known or suspected daily use of opioids for 7 or more consecutive days withinthe previous 6 months
Study Design
Study Description
Connect with a study center
Todd Bertoch
Salt Lake City, Utah 84101
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.